Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: A case-control study

Rheumatology

Volumn 42, Issue 5, 2003, Pages 660-664

  Eden, A ^a   Mahr, Alfred ^b   Servant, A ^a   Radjef, N ^b   Amard, S ^a   Mouthon, L ^b   Garbarg Chenon, A ^a   Guillevin, L ^b  

^a ARMAND TROUSSEAU HOSPITAL   (France)

^b UNIVERSITÉ PARIS 13   (France)

Author keywords

ANCA; B19; Erythrovirus; V9; Vasculitis

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; NEUTROPHIL CYTOPLASMIC ANTIBODY; VIRUS DNA; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BLOOD ANALYSIS; CHURG STRAUSS SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA INFECTIOSUM; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MALE; NECROTIZING ARTERITIS; PARVOVIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; WEGENER GRANULOMATOSIS; ACUTE DISEASE; BLOOD; CASE CONTROL STUDY; CHRONIC DISEASE; IMMUNOLOGY; ISOLATION AND PURIFICATION; MIDDLE AGED; STATISTICAL MODEL; VASCULITIS; VIROLOGY; VIRUS INFECTION;

ACUTE DISEASE; ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, VIRAL; CASE-CONTROL STUDIES; CHRONIC DISEASE; CHURG-STRAUSS SYNDROME; DNA, VIRAL; ERYTHROVIRUS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOGISTIC MODELS; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; VASCULITIS; WEGENER GRANULOMATOSIS;

EID: 0012511937     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/keg206     Document Type: Article

References (31)

1. Falk RJ, Jennette JC. ANCA small-vessel vasculitis. J Am Soc Nephrol 1997;8:314-22.
2. Hoffman GS, Kerr GS, Leavitt RY et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116:488-98.
3. Guillevin L, Durand-Gasselin B, Cevallos R et al. Microscopic polyangiitis: clinical and laboratory findings in eighty-five patients. Arthritis Rheum 1999;42:421-30.
4. Guillevin L, Cohen P, Gayraud M, Lhote F, Jarrousse B, Casassus P. Churg-Strauss syndrome. Clinical study and long-term follow-up of 96 patients. Medicine (Baltimore) 1999;78:26-37.
5. Russell KA, Specks U. Are antineutrophil cytoplasmic antibodies pathogenic? Experimental approaches to understand the antineutrophil cytoplasmic antibody phenomenon. Rheum Dis Clin North Am 2001;27:815-32,vii.
6. Murphy FA, Fauquet CM, Bishop DHL et al. Virus taxonomy - classification and nomenclature of viruses: sixth report of the International Committee on Taxonomy of Viruses. Vienna: Springer-Verlag, 1995.
7. Brown KE. Human parvovirus B19 epidemiology and clinical manifestations. In: Young NS, ed. Human parvovirus B19. New York: Karger, 1997:42-55.
8. Nguyen QT, Sifer C, Schneider V et al. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 1999;37:2483-7.
9. Nguyen QT, Sifer C, Schneider V, Bernaudin F, Auguste V, Garbarg-Chenon A. Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia [letter]. Lancet 1998;352:1524.
10. Servant A, Laperche S, Lallemand F et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002;76:9124-34.
11. Finkel TH, Torok TJ, Ferguson PJ et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994;343:1255-8.
12. Corman LC, Staud R. Association of Wegener's granulomatosis with parvovirus B19 infection: comment on the concise communication by Nikkari et al. Arthritis Rheum 1995;38:1174-5.
13. Nikkari S, Mertsola J, Korvenranta H, Vainionpää R, Toivanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 1994;37:1707-8.
14. Gaches F, Loustaud V, Vidal E et al. Periarteritis nodosa and parvovirus B19 infection [French]. Rev Méd Intern 1993;14:323-5.
15. Leruez-Ville M, Lauge A, Morinet F, Guillevin L, Deny P. Polyarteritis nodosa and parvovirus B19 [letter]. Lancet 1994;344:263-4.
16. Nigro G, Zerbini M, Krzysztofiak A et al. Active or recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994;343:1260-1.
17. Stand R, Corman LC. Association of parvovirus B19 infection with giant cell arteritis. Clin Infect Dis 1996; 22:1123.
18. Chou TN, Hsu TC, Chen RM, Lin LI, Tsay GJ. Parvovirus B19 infection associated with the production of anti-neutrophil cytoplasmic antibody (ANCA) and anticardiolipin antibody (aCL). Lupus 2000;9:551-4.
19. Leavitt RY, Fauci AS, Bloch DA et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990; 33:1101-7.
20. Masi AT, Hunder GG, Lie JT et al. The American College of Rheumatology 1990 criteria for the classification of Churg-Strauss syndrome (allergic granulomatosis and angiitis). Arthritis Rheum 1990;33:1094-100.
21. Jennette JC, Falk RJ, Andrassy K et al. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994;37:187-92.
22. Bruu AL, Nordbo SA. Evaluation of five commercial tests for detection of immunoglobulin M antibodies to human parvovirus B19. J Clin Microbiol 1995;33:1363-5.
23. Kerr S, O'Keeffe G, Kilty C, Doyle S. Undenatured parvovirus B19 antigens are essential for the accurate detection of parvovirus B19 IgG. J Med Virol 1999; 57:179-85.
24. Bengtsson A, Widell A, Elmstahl S, Sturfelt G. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheum Dis 2000;59:64-6.
25. Heegaard ED, Qvortrup K, Christensen J. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: serologic cross-reactivity with erythrovirus B19. J Med Virol 2002;66:246-52.
26. Elling H, Olsson AT, Elling P. Human parvovirus and giant cell arteritis: a selective arteritic impact? Clin Exp Rheumatol 2000;18(4 Suppl. 20):S12-4.
27. Gabriel SE, Espy M, Erdman DD, Bjornsson J, Smith TF, Hunder GG. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum 1999;42:1255-8.
28. Helweg-Larsen J, Tarp B, Obel N, Baslund B. No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis. Rheumatology 2002;41:445-9.
29. Kiraz S, Ozturk MA, Ertenli I, Calguneri M. Parvovirus B19 infection in Behcet's disease. Ann Rheum Dis 2001; 60:814-5.
30. Nikkari S, Vainionpää R, Toivanen P et al. Association of Wegener's granulomatosis with parvovirus B19 infection: comment on the concise communication by Nikkari et al. Reply. Arthritis Rheum 1995;38:1174-5.
31. Choi HK, Lamprecht P, Niles JL, Gross WL, Merkel PA. Subacute bacterial endocarditis with positive cytoplasmic antineutrophil cytoplasmic antibodies and anti-proteinase 3 antibodies. Arthritis Rheum 2000;43:226-31.